Access to both oral and injectable branded medications depends on your individual needs, preferences, and insurance stipulations
Alternative medicine review, 11(4)
Gotoh T, Hattori S, Nakamura S, Kitayama H, Noda M, Takai Y, Kaibuchi K, Matsui H, Hatase O, Takahashi H, Kurata T
At 48 weeks, there was progressive decrease in weight (secondary outcome) ranging from 8.7% to 24.2% with retatrutide versus 2.1% with placebo [3]
Injection pain is the brief discomfort felt during needle insertion (usually minimal with semaglutide), while post-injection reactions like redness or swelling develop afterward and are unrelated to injection technique